Started in 1978, Biogen is a number one world wide biotechnology organization which has pioneered a number of breakthrough improvements including a broad portfolio of medicines to take care of numerous sclerosis, the initial authorized treatment method for spinal muscular atrophy, two co-made treatment options to handle a defining pathology of Alzh